| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | bid1870 | gCSI | pan-cancer | AAC | 0.16 | 0.005 |
| mRNA | Curcumin | CTRPv2 | pan-cancer | AAC | -0.096 | 0.005 |
| mRNA | YM-155 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.006 |
| mRNA | temsirolimus | GDSC1000 | pan-cancer | AAC | -0.092 | 0.007 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.13 | 0.009 |
| mRNA | GMX-1778 | CTRPv2 | pan-cancer | AAC | -0.092 | 0.01 |
| mRNA | Bicalutamide | GDSC1000 | pan-cancer | AAC | 0.087 | 0.01 |
| mRNA | PHA-665752 | GDSC1000 | pan-cancer | AAC | 0.14 | 0.01 |
| mRNA | STF-31 | CTRPv2 | pan-cancer | AAC | -0.088 | 0.01 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.082 | 0.01 |